Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Injections given subcutaneously at the sight of vaccination on the day of the vaccination and for three days afterwards

Given subcutaneously once every three weeks for a total of three vaccines

Cream applied to the skin at the injection sight 2 hours before injection and for 3 days following the injection